Current Affairs - Science - Discussion

Novo Medi Sciences introduced NEXIPOX PLUS®, an advanced Varicella (chickenpox) vaccine tailored for Indian clinical and environmental conditions. The vaccine uses a 2X trehalose-based stabiliser system, which enhances viral stability, preserves potency, and reduces allergenic reactions associated with gelatin and mannitol. This launch represents India’s first upgraded formulation of the Varicella vaccine, reflecting innovation in vaccine development and addressing the need for safer, more effective immunisation options in the country. The product is positioned to improve vaccination outcomes and public health protection.